
    
      Primary liver cancer (PLC) is one of the most common malignant tumors of digestive system and
      also a serious threat to the health and safety of Chinese people, and has caused serious
      economic burden to the country. Research purposes: To understand the clinical characteristics
      of patients with primary liver cancer (PLC) in China; To investigate the etiology and
      pathogenesis of PLC in China; To understand the current status of clinical treatment of PLC
      in China, and to analyze the gaps among these conditions and domestic treatment guidelines,
      industry consensus, the international treatment guidelines; To understand the different
      treatment options and its clinical outcomes, and to explore the best treatment options; To
      explore the best clinical pathway of PLC multidisciplinary consultation; To provide the basis
      for the development of clinical guidelines for PLC in China.
    
  